Emmanuel André

Deputy head of Clinic (Medical Microbiology)

KU Leuven

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Emmanuel André is the Deputy Head of Clinic in Medical Microbiology at KU Leuven, Belgium. His research primarily focuses on the surveillance and control of infectious diseases, with recent works including studies on metagenomics for respiratory viruses, tuberculosis intervention strategies, and the genomic surveillance of SARS-CoV-2. Dr. André's contributions are critical in understanding the dynamics of viral infections and improving public health responses.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (9)

Coralie Henin

Université libre de Bruxelles

BELGIUM

View details

Guy Baele

Associate Professor

Katholieke Universiteit Leuven Rega Institute for Medical Research

BELGIUM

View details

Veerle Matheeussen

BELGIUM

View details

Bruno Verhasselt

Ghent University Hospital

BELGIUM

View details

Simon Dellicour

Université libre de Bruxelles

BELGIUM

View details

Mandy Bloemen

Katholieke Universiteit Leuven Rega Institute for Medical Research

BELGIUM

View details

Nicolas Yin

Université libre de Bruxelles

BELGIUM

View details

Thomas Demuyser

Vrije Universiteit Brussel (VUB)

BELGIUM

View details

Timothy Walker

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Emmanuel André

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Shotgun metagenomics on indoor air for surveillance of respiratory, enteric, and skin viruses in a Belgian daycare setting, January to December 2022

Analyzing Satellite Imagery to Target Tuberculosis Control Interventions in Densely Urbanized Areas of Kigali, Rwanda: Cross-Sectional Pilot Study

Multicenter study of the performance of NTM Elite agar for the detection of nontuberculous mycobacteria from patients with cystic fibrosis

Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres

Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging Variants

Two Separate Clusters of SARS-CoV-2 Delta Variant Infections in A Group of 41 Students Travelling from India: An Illustration of the Need for Rigorous Testing and Quarantine

Nationwide Harmonization Effort for Semi-Quantitative Reporting of SARS-CoV-2 PCR Test Results in Belgium

Severity of COVID-19 among Hospitalized Patients: Omicron Remains a Severe Threat for Immunocompromised Hosts

Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies.

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.

Collaborators (9)

Coralie Henin

Guy Baele

Veerle Matheeussen

Bruno Verhasselt

Simon Dellicour

Mandy Bloemen

Nicolas Yin

Thomas Demuyser

Timothy Walker

Make your next move.